Cisatracurium 200 mg vials recalled after subpotent stability assay results
Somerset Therapeutics is recalling 28,660 vials of Cisatracurium Besylate Injection, 200mg/20mL, after out of specification assay results during long term stability testing.
- Product
- CISATRACURIUM BESYLATE — CISATRACURIUM BESYLATE (CISATRACURIUM BESYLATE)
- Category
- Drug
- Distribution
- Distributed nationwide